Qube Research & Technologies Ltd

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1729829 LONDON, X0

Position in HRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$439,069

+$414,785 QoQ

Shares Held

1,021,092

+3263.8% QoQ

Ownership

0.538%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 161 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. HRTX ranks #130 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$439,069	1,021,092	+3263.8%	Shares	Sole	2026-08-14
2026-03-31	$24,284	30,355	-77.1%	Shares	Sole	2026-05-15
2025-06-30	$274,858	132,782	-88.4%	Shares	Sole	2025-08-14
2024-09-30	$2,281,849	1,146,658	+126.1%	Shares	Sole	2024-11-14
2024-06-30	$1,775,294	507,227	-9.7%	Shares	Sole	2024-08-14
2024-03-31	$1,556,695	561,984	+9233.7%	Shares	Sole	2024-05-14
2023-09-30	$6,201	6,021	-98.8%	Shares	Sole	2023-11-13
2022-12-31	$1,256,890	502,756	+385.4%	Shares	Sole	2023-02-14
2022-09-30	$437,128	103,585	+30.6%	Shares	Sole	2022-11-14
2022-06-30	$221,238	79,297	+2.9%	Shares	Sole	2022-08-15
2022-03-31	$440,903	77,081	+567.8%	Shares	Sole	2022-05-09
2020-03-31	$135,514	11,543	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.